Intellia Therapeutics (NASDAQ:NTLA) highlighted top-line results from its Phase III HAELO trial evaluating lonvo-z, an investigational in vivo CRISPR-based gene-editing therapy for hereditary angioedema (HAE), and provided an update on regulatory progress during a company conference call.
Company o
Source link
Source: Earnings Call of MOIL Ltd Source link
Conditions are ripe for an oil price crash. There, I said it. You can bag me out in future if I’m wrong. With OPEC+ meeting in a few days to discuss raising supply, traders have been selling first and asking questions later. Brent crude oil was down 6.4% on the week at time of writing….
Operator Good afternoon, ladies and gentlemen, and welcome to the GEN Restaurant Group, Inc. Fourth Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, March 31, 2026. And now I would like to turn the conference over to Tom Croal, the company’s Chief Financial Officer. Please go ahead. Thomas CroalCFO &…
Vontier Corporation (NYSE:VNT) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Ryan Edelman – Vice President, Investor RelationsMark Morelli – President and CEOAnshooman Aga – CFO Conference Call Participants Nigel Coe – Wolfe Research LLCJulian Mitchell – Barclays Investment BankDavid Ridley-Lane – Bank of America Operator Good morning, ladies and…
Exclusive: Eleos Life to unveils 24/7 AI voice agent Source link
Watch this video on YouTube!youtu.be/M8KXYuSb7cEStocks Hit With “Unprecedented” SellingPrice Levels to Watch for Stocks to Pullback toStocks Are Moderately Oversold According to Short-Term 4-Hour ChartsCandlestick Analysis at Specific LevelsWhat to Expect from Stocks in the Next Few WeeksLong-Term Stocks Are Still BullishMarket Breadth Shows that Stocks are Moderately OversoldBearish Divergence on Junk BondsTreasury Bonds Rally…